Collaboration will Drive AI-Powered Advancements in Next-Generation Protein Sequencing™ and Accelerated Data Processing BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus™, and advance Quantum-Si’s core technologies of amino acid binders and aminopeptidases using NVIDIA AI […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with Leader Life Sciences. Under the agreement, Leader Life Sciences becomes a distributor of Bio-Techne’s portfolio across the Gulf Cooperation Council (GCC) countries, which include Bahrain, Oman, Qatar, […]

Sets stage for advanced scientific discovery of new diagnostic biomarkers and treatments for disease BRANFORD, Conn. & BLOOMINGTON, Minn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKYT), the trusted technology realization partner, announced today they will jointly expand their relationship to support development of Proteus™, Quantum-Si’s […]

Combined Teams Aim to Deliver Novel Proteomics Platform in Under Two Years BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and Planet Innovation today announced that they will partner on the development and manufacturing of Quantum-Si’s novel proteomics platform, Proteus™. Planet Innovation has a team of over four hundred people with […]

Columbia University scientist recognized for his contributions to sustainability and improving environmental health SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) announced today that Adeyemi Adeleye, Ph.D., has received the Agilent 2024 Early Career Professor Award for his contribution to environmental health and sustainability, developing green analytical technologies, methods, or laboratory working environments. Dr. Adeleye is […]

Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis. Cambridge, UK: Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent Technologies, a leading tools provider in the genomics sector. The agreement offers select customers […]

VANCOUVER, BC — Complete Genomics, a San Jose, Calif.-based genomic sequencer manufacturer, today announced at the 2024 Association for Molecular Pathology (AMP) Annual Meeting & Expo the launch of its mpox (MPXV) virus amplicon sequencing panel, part of its sequencing product portfolio for pathogenic microorganisms. Complete Genomics is at AMP this week at Booth #1524. The recent […]

Cologne – Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co., Ltd. Under this agreement, TOMY will serve as Singleron’s exclusive distributor in Japan, providing access to Singleron’s comprehensive range of single cell analysis products and services. TOMY will distribute Singleron’s innovative offerings, which cover […]

San Jose, California — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for infectious disease research. Takara Bio USA is now accepting orders of the SmartChip ND Real-Time PCR System. The SmartChip ND […]

Integral Molecular, a leader in antibody discovery and characterization, has been awarded $2.7 million by the NIH Commercialization Readiness Pilot (CRP) Program. This funding will support FDA-qualification of Integral Molecular’s Membrane Proteome Array™ (MPA), a next-generation technology that provides critical safety data required for Investigational New Drug (IND) filings of biologic drugs. The MPA is […]